Nanjing CompTECH Composites Corporation

SZSE:301591 Stok Raporu

Piyasa değeri: CN¥3.0b

Nanjing CompTECH Composites Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Nanjing CompTECH Composites has been growing earnings at an average annual rate of 0.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 8.8% per year. Nanjing CompTECH Composites's return on equity is 8.7%, and it has net margins of 18%.

Anahtar bilgiler

0.7%

Kazanç büyüme oranı

-15.4%

EPS büyüme oranı

Chemicals Sektör Büyümesi12.1%
Gelir büyüme oranı8.8%
Özkaynak getirisi8.7%
Net Marj18.0%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Why Nanjing CompTECH Composites' (SZSE:301591) Shaky Earnings Are Just The Beginning Of Its Problems

Sep 02
Why Nanjing CompTECH Composites' (SZSE:301591) Shaky Earnings Are Just The Beginning Of Its Problems

Recent updates

Why Nanjing CompTECH Composites' (SZSE:301591) Shaky Earnings Are Just The Beginning Of Its Problems

Sep 02
Why Nanjing CompTECH Composites' (SZSE:301591) Shaky Earnings Are Just The Beginning Of Its Problems

Gelir ve Gider Dağılımı

Nanjing CompTECH Composites nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SZSE:301591 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 24419755025
30 Jun 24403714824
31 Mar 24390734522
31 Dec 23390754122
01 Jan 23372733919
31 Dec 1613315400
31 Dec 1513228210
31 Dec 1412030190

Kaliteli Kazançlar: 301591 has a high level of non-cash earnings.

Büyüyen Kar Marjı: 301591's current net profit margins (18%) are lower than last year (19.4%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: Insufficient data to determine if 301591's year-on-year earnings growth rate was positive over the past 5 years.

Büyüme Hızlandırma: Insufficient data to compare 301591's past year earnings growth to its 5-year average.

Kazançlar vs. Sektör: 301591 earnings growth over the past year (0.7%) exceeded the Chemicals industry -3.8%.


Özkaynak Getirisi

Yüksek ROE: 301591's Return on Equity (8.7%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin